Our Pipeline
The primary focus of Automera’s pipeline lies in advancing assets against targets that will showcase the adaptability and efficacy of our platform. These endeavors will provide further validation of our platform’s capabilities in confronting intricate and innovative targets that conventional methods struggle to tackle.
Thanks to autophagy’s broad degradation capacities, our platform transcends the scope of proteins alone. It holds the potential to address protein aggregates, dysfunctional mitochondria, viruses, bacteria, and an array of cellular components. This exceptional versatility significantly broadens the potential applications of our platform in combatting diverse disease mechanisms.
Should you possess a challenging-to-address target, we encourage collaborative efforts to facilitate its efficient degradation.